Statistics in Biopharmaceutical Research

Statistics in Biopharmaceutical Research 由 Taylor and Francis Ltd. 出版，属中科院医学大类（2025 升级版4区）。按 OpenAlex 近年发文统计，该刊主要发表 Statistical Methods in Clinical Trials、Advanced Causal Inference Techniques、Health Systems, Economic Evaluations, Quality of Life 等主题的论文，这 3 个主题约占 52.1%，主导子领域为 Statistics and Probability。（根据 OpenAlex 主题统计与中科院分区数据生成）

Statistics in Biopharmaceutical Research ( SBR), publishes articles that focus on the needs of researchers and applied statisticians in biopharmaceutical industries; academic biostatisticians from schools of medicine, veterinary medicine, public health, and pharmacy; statisticians and quantitative analysts working in regulatory agencies (e.g., U.S. Food and Drug Administration and its counterpart in other countries); statisticians with an interest in adopting methodology presented in this journal to their own fields; and nonstatisticians with an interest in applying statistical methods to biopharmaceutical problems. Statistics in Biopharmaceutical Research accepts papers that discuss appropriate statistical methodology and information regarding the use of statistics in all phases of research, development, and practice in the pharmaceutical, biopharmaceutical, device, and diagnostics industries. Articles should focus on the development of novel statistical methods, novel applications of current methods, or the innovative application of statistical principles that can be used by statistical practitioners in these disciplines. Areas of application may include statistical methods for drug discovery, including papers that address issues of multiplicity, sequential trials, adaptive designs, etc.; preclinical and clinical studies; genomics and proteomics; bioassay; biomarkers and surrogate markers; models and analyses of drug history, including pharmacoeconomics, product life cycle, detection of adverse events in clinical studies, and postmarketing risk assessment; regulatory guidelines, including issues of standardization of terminology (e.g., CDISC), tolerance and specification limits related to pharmaceutical practice, and novel methods of drug approval; and detection of adverse events in clinical and toxicological studies. Tutorial articles also are welcome. Articles should include demonstrable evidence of the usefulness of this methodology (presumably by means of an application). The Editorial Board of SBR intends to ensure that the journal continually provides important, useful, and timely information. To accomplish this, the board strives to attract outstanding articles by seeing that each submission receives a careful, thorough, and prompt review. . ASA Statement on Justice, Equity, Diversity, and Inclusion (JEDI) The leadership of the American Statistical Association commits to strengthening our professional community by making it more just, equitable, d

摘自期刊官网 Aims & Scope

研究方向（LetPub）：MATHEMATICAL & COMPUTATIONAL BIOLOGY-STATISTICS & PROBABILITY

主编 Weili He出版商官网

中科院期刊分区表

期刊官网公布的 JCR / CiteScore 分区

• JCR Q2 · 最佳分区 · 2025 年度
• CiteScore Q2 · 2025 年度

出版商自述数据，JCR 以 Clarivate、CiteScore 以 Scopus 公布为准；与中科院分区是不同体系。出版商官网

数据库收录

SCIEScopusLetPub

国际期刊预警名单：各版本均未列入LetPub

期刊官网自述收录

Web of ScienceEmbase出版商官网

其他：BIOSIS Previews、EBSCOhost、Genamics JournalSeek、Clarivate Analytics、Biological Abstracts (Online)、Biotechnology Citation Index (Online)

期刊官网列出的收录清单，未与各数据库逐一核对；Web of Science 各子库以上方记录为准。

不同版本、大类与小类分别展示，不将不同评价口径合并为一个分区值；投稿与考核前请确认所在机构采用的版本。

影响力指标

影响因子

1.54LetPub · 2026-09-13

影响因子（出版商公布） 2025

1.6出版商官网 · 2026-09-30

五年影响因子（出版商公布） 2025

1.6出版商官网 · 2026-09-30

CiteScore 2026-06

3.2LetPub · 2026-09-13

CiteScore（出版商公布） 2025

3.2出版商官网 · 2026-09-30

SJR 2026-06

0.87LetPub · 2026-09-13

SJR（出版商公布） 2025

0.87出版商官网 · 2026-09-30

SNIP 2026-06

0.97LetPub · 2026-09-13

SNIP（出版商公布） 2025

0.97出版商官网 · 2026-09-30

h-index

11LetPub · 2026-09-13

h-index

40OpenAlex · 2026-10-01

i10-index

219OpenAlex · 2026-10-01

两年平均被引

1.16OpenAlex · 2026-10-01

自引率

25%LetPub · 2026-09-13

Gold OA 文章占比

9.76%LetPub · 2026-09-13

发文规模

年文章数

59LetPub · 2026-09-13

年下载量（出版商公布） 2025

99,000出版商官网 · 2026-09-30

不同来源的统计口径与观测时间不同，页面保留各来源原值；“出版商公布”为期刊官网自述数据。

其他来源

平均审稿速度（社区反馈）

期刊官网数据：平均Submission to first decision: 65 days; Submission to first post-review decision: 101 days; Acceptance to online publication: 48 days;网友分享经验：>12周，或约稿LetPub · 2026-09-13

平均录用比例（社区反馈）

41%LetPub · 2026-09-13

录用率（出版商公布） 2025

39%出版商官网 · 2026-09-30

投稿到首次决定 2025

33 天出版商官网 · 2026-09-30

外审后首次决定 2025

46 天出版商官网 · 2026-09-30

接收到发表 2025

66 天出版商官网 · 2026-09-30

社区反馈来自投稿者样本，置信度 0.5，不代表期刊承诺；“出版商公布”的时间节点定义以官网为准。

混合期刊的文章处理费仅在作者选择开放获取发表时收取；按订阅方式发表通常不收费。

费用以期刊官网为准；不同来源的观测时间可能不同，页面保留各来源原值，不做平均。

摘录来自期刊官网页面，仅保留原文片段；“模型摘要”由 Workers AI 生成并经原文校验，以官网为准。

出版商

Taylor and Francis Ltd.

出版国家或地区

UNITED STATES

出版语言

English

出版周期

Quarterly

创刊年份

2009

ISSN

1946-6315

学会 / 主办单位

American Statistical Association

官网最新一期

Volume 18, Issue 3（2026 年）

官方链接

• 期刊主页 ↗OpenAlex
• 投稿系统 ↗出版商官网
• 作者指南 ↗LetPub
• 专刊 / 特刊征稿 ↗出版商官网